Atria Investments Inc Raises Holdings in CME Group Inc. (NASDAQ:CME)

Atria Investments Inc increased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 2.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 29,740 shares of the financial services provider’s stock after acquiring an additional 690 shares during the period. Atria Investments Inc’s holdings in CME Group were worth $6,906,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in CME. Truvestments Capital LLC purchased a new position in CME Group in the third quarter worth approximately $26,000. SJS Investment Consulting Inc. boosted its position in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares during the period. Dunhill Financial LLC boosted its position in shares of CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the period. Financial Life Planners purchased a new position in shares of CME Group during the fourth quarter worth $32,000. Finally, Fortitude Family Office LLC boosted its position in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after buying an additional 83 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of CME opened at $254.04 on Friday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $258.78. The stock’s 50 day moving average is $239.65 and its two-hundred day moving average is $230.23. The firm has a market capitalization of $91.55 billion, a PE ratio of 26.27, a P/E/G ratio of 6.76 and a beta of 0.57. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group announced that its Board of Directors has approved a stock buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is currently 51.71%.

Insider Buying and Selling at CME Group

In other news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. The trade was a 15.73 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,076 shares of company stock valued at $4,271,496. 0.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Barclays raised their price target on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Piper Sandler raised their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Oppenheimer increased their price objective on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada increased their price objective on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $235.50.

View Our Latest Stock Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.